Novocure is a global publicly-traded commercial-stage oncology company developing a profoundly different cancer treatment therapy called tumor treating fields (TTFields) for patients with solid tumors.
TTFields therapy is a non-invasive, novel, antimitotic treatment modality which utilizes proprietary technology attempting to slow or reverse tumor progression by inducing tumor cell death.
Novocure's commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma (GBM) in the USA, Europe and Israel.
Novocure has ongoing or completed clinical trials and is further expanding its efforts into several other solid tumor indications - non-small cell lung cancer, pancreatic cancer and other types of solid cancers.To support our team in Baar, Switzerland we are looking for a:
Vice President, Value and Access StrategyThe VP Value & Access will lead Value (including HEOR), Pricing and Access Strategy, and Pricing Governance across all indications with a primary focus on our businesses in Europe and Japan.
The leader will expand our Value team, including building up our HEOR team to cover multiple new indications.
Additionally, the leader will define the Pricing and Access Strategy for each new indication in collaboration, including market sequencing, with our operating businesses.
Post launches, this role will also oversee Pricing Governance to ensure our reimbursement submissions and negotiations are in line with our approved reimbursement levels.This role will be a key partner to the European and Japan General Managers and Market Access directors in preparing reimbursement submissions and determining our access strategy around the submission.
The leader in this role will need to establish and implement a consistent strategy for reimbursement submissions, and then support the local teams in executing the vision.
The VP Value and Access will also be responsible for ensuring our market access directors collaborate and feel a sense of community while still reporting to the local GMs.
The leader will be a key member of the business leadership team, reporting to Novocure's President.
Additionally, this individual will work closely with the VP Public Affairs who leads the US Policy & Reimbursement teams to ensure the US business has the support needed to ensure timely coverage from private and public payers.Your responsibilities:
Lead Value, Pricing and Access teams and recruit new talent to strengthen our capabilitiesDeliver the HEOR and Global Value Dossiers necessary for all indications and all marketsEstablish, communicate and support a consistent approach to negotiations with payers and regulators around reimbursement submissions in Europe and JapanPartner closely with the GMs and Market Access teams in Europe and Japan to prepare dossier submissionsServe as the core, corporate level subject matter expert on all matters related to reimbursement trends outside the United StatesMaintain our Pricing Governance procedures and reporting across all markets, including USEnsure best-in-class Value and HEOR capabilities to support all markets, including USServe as the senior leader and CoE for the community of Market Access directors reporting to the local in-country leadership; foster collaboration and communityPartner closely with the Product and Portfolio Strategy team on R&D prioritization and market sequencing for launchesQualifications:
Demonstrated success leading a Value, Pricing and Access teamDemonstrated success working in cross-functional teams across departmentsPrior experience leading products through a market launch and successful reimbursementAbility to interact and drive consensus with C-level executivesStrong analytical and communication skillsFluent in English; preferred if also competent in German or FrenchWe are looking forward to receiving your application to Natalia Münchow, Senior Talent Partner.
Please find more information about Novocure and our therapy on our website *** or by consulting our patient testimonial videos.
•
CH - Hermikon
January 19, 2025
Als Teil des IT-Managementteams und gemeinsam mit unserem CDC-Partner stellst Du sicher, dass unsere Organisation bestens gegen aktuelle und zukünftige Cyber-Bedrohungen gewappnet ist. • Du entwickelst innovative Lösungen und setzt die Informationssicherheit im Einklang mit unseren...
CH - Uster
January 19, 2025
Damit sich unsere rund 240 Servicetechniker im Bereich Heizen Deutschschweiz voll auf Inbetriebnahmen, Wartungen und Störungshebungen konzentrieren können und unsere Kunden unseren Service Excellence erleben, brauchen wir genau dich für unsere Disposition Heizen Deutschschweiz! Werde unser...
US - CA - San Francisco
January 18, 2025
JOB SUMMARY: • The Device Support Specialist (DSS) plays an essential role in supporting commercial oncology patients using Tumor Treating Fields (TTFields). The DSS focuses on educating patients and their caregivers on TTFields according to product labeling and integrating TTFields into daily...
AU - banana
January 16, 2025
Global Quality Internal Auditor - Medical Devices Novocure is a global publicly-traded commercial-stage oncology company developing a profoundly different cancer treatment therapy called tumor treating fields (TTFields) for patients with solid tumors. • TTFields therapy is a non-invasive, novel,...
US - NJ - Princeton
January 13, 2025
Description: • The Regional Device Support Specialist (RDSS) is a key position within the US Business Unit. The primary role of this position is to support commercial and clinical trial oncology patients utilizing the Tumor Treating Fields (TTFields) device over an assigned region in the US....
US - NJ - Boonton
January 13, 2025
Position: Medical Science Liaison (MSL), US Thoracic (Northeast) • Location: Parsippany, NJ (commutable distance to a major metropolitan airport in New Jersey, Pennsylvania, Maryland, Delaware, or surrounding cities) • Description: • The US CNS Medical Science Liaison (MSL) is a key...
CH - Baar
January 5, 2025
Novocure is a global publicly-traded commercial-stage oncology company developing a profoundly different cancer treatment therapy called tumor treating fields (TTFields) for patients with solid tumors. • TTFields therapy is a non-invasive, novel, antimitotic treatment modality which utilizes...